The impact of strengthening chronic disease management outpatient services on the prognosis of coronary heart disease patients

Objective: To evaluate the impact of strengthening chronic disease management outpatient services on medication adherence, cardiovascular event readmission rate, and cardiac function rating in patients with coronary heart disease. Method: From January 2012 to December 2013, 180 patients diagnosed with coronary heart disease who visited the Cardiovascular Department of the First Affiliated Hospital of Chengdu Medical College were divided into a strengthened management group and a general management group(control group). The strengthened management group will follow up every 2 weeks through standardized chronic disease management outpatient methods, and undergo regular testing every 3 months. The general management group will follow up through monthly outpatient or telephone visits. Observe medication adherence, readmission rate of cardiovascular events, and cardiac function rating(NYHA rating) in two groups of patients. Result: After 2 years of follow-up, it was found that in the strengthened management group, aspirin/clopidogrel(74%) vs．54% ，P＜0.01) 、 The medication rates of statins(69% vs. 46%, P<0.01), ACEI/ARB(76% vs. 46%, P<0.01), and beta blockers(63% vs. 42%, P<0.05) were all higher than those of the general management group; The readmission rate due to cardiovascular events is also relatively low(26% vs. 42%, P<0.05). Conclusion: Strengthening standardized management of coronary heart disease patients can help improve medication compliance and reduce the readmission rate of cardiovascular events.